Lu Zhan

537 total citations
26 papers, 393 citations indexed

About

Lu Zhan is a scholar working on Ophthalmology, Molecular Biology and Cancer Research. According to data from OpenAlex, Lu Zhan has authored 26 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Ophthalmology, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Lu Zhan's work include Ocular Infections and Treatments (10 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Lu Zhan is often cited by papers focused on Ocular Infections and Treatments (10 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Lu Zhan collaborates with scholars based in China, United States and Brunei. Lu Zhan's co-authors include Jing Lin, Yingxue Zhang, Guiqiu Zhao, Xudong Peng, Xue Tian, Takashi Kishimoto, B. W. Rice, Stephen Lee, Kenneth D. Campbell and Jae‐Beom Kim and has published in prestigious journals such as PLoS ONE, International Journal of Biological Macromolecules and Investigative Ophthalmology & Visual Science.

In The Last Decade

Lu Zhan

23 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Zhan China 12 139 91 64 58 55 26 393
Xiumei Yang China 10 207 1.5× 111 1.2× 69 1.1× 77 1.3× 36 0.7× 33 481
Xiaoqin Zheng China 13 156 1.1× 23 0.3× 57 0.9× 74 1.3× 41 0.7× 27 397
Jiaxin Zhang China 11 193 1.4× 13 0.1× 33 0.5× 61 1.1× 22 0.4× 40 461
Hsun‐Hsien Chang United States 10 180 1.3× 27 0.3× 26 0.4× 24 0.4× 19 0.3× 20 355
Naeem Mahmood Ashraf Pakistan 9 446 3.2× 19 0.2× 150 2.3× 43 0.7× 36 0.7× 51 595
Lihua Mo China 10 107 0.8× 15 0.2× 28 0.4× 67 1.2× 23 0.4× 24 304
Angela Ianaro Italy 11 164 1.2× 13 0.1× 48 0.8× 132 2.3× 37 0.7× 14 507
Jiayi Wei China 10 170 1.2× 13 0.1× 48 0.8× 53 0.9× 24 0.4× 18 382
Jorge Ramiro Domínguez-Rodríguez Mexico 11 192 1.4× 14 0.2× 53 0.8× 95 1.6× 78 1.4× 15 365

Countries citing papers authored by Lu Zhan

Since Specialization
Citations

This map shows the geographic impact of Lu Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Zhan more than expected).

Fields of papers citing papers by Lu Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Zhan. The network helps show where Lu Zhan may publish in the future.

Co-authorship network of co-authors of Lu Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Zhan. A scholar is included among the top collaborators of Lu Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Zhan. Lu Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhan, Lu, et al.. (2025). Clinically Related Factors of Liver Failure in Patients With Liver Cirrhosis After Hepatectomy. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 35(4).
3.
Tian, Xue, Lu Zhan, Xiaojing Long, et al.. (2024). Multifunctional natamycin modified chondroitin sulfate eye drops with anti-inflammatory, antifungal and tissue repair functions possess therapeutic effects on fungal keratitis in mice.. International Journal of Biological Macromolecules. 279(Pt 2). 135290–135290. 3 indexed citations
4.
Zhan, Lu, et al.. (2024). The Therapeutic Role and Mechanism of Glabridin Under Aspergillus fumigatus Infection. Journal of Ocular Pharmacology and Therapeutics. 40(1). 89–99.
5.
Zhan, Lu, et al.. (2024). Clonorchis sinensis on the prognosis of patients with spontaneous rupture of Hepatocellular Carcinoma: An inverse probability of treatment weighting analysis. PLoS neglected tropical diseases. 18(2). e0011987–e0011987. 4 indexed citations
6.
Zhan, Lu, et al.. (2024). Safe Threshold Rate of Indocyanine Green Retention and Intervention of Nutrition Management After Hepatectomy. Nutrition and Cancer. 77(3). 372–379. 1 indexed citations
7.
Zhan, Lu, et al.. (2023). High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells. Journal of Hepatocellular Carcinoma. Volume 10. 57–68. 4 indexed citations
9.
Zhu, Yunan, Jing Lin, Yingxue Zhang, et al.. (2023). Quercetin protects against Aspergillus fumigatus keratitis by reducing fungal load and inhibiting TLR-4 induced inflammatory response. Cytokine. 171. 156356–156356. 12 indexed citations
10.
Zhan, Lu, Xue Tian, Jing Lin, et al.. (2023). Honokiol reduces fungal burden and ameliorate inflammation lesions of Aspergillus fumigatus keratitis via Dectin-2 down-regulation. International Immunopharmacology. 118. 109849–109849. 12 indexed citations
11.
Zhan, Lu, Qiang Li, Yueqiang Wen, et al.. (2023). Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action. Frontiers in Pharmacology. 14. 1257450–1257450. 10 indexed citations
12.
Yang, Xihua, Lu Zhan, Jie Zhang, et al.. (2023). Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma. BMC Cancer. 23(1). 10–10. 12 indexed citations
13.
Peng, Xudong, Jing Lin, Yingxue Zhang, et al.. (2022). The therapeutic potential of chondroitin sulfate in Aspergillus fumigatus keratitis. Molecular Immunology. 147. 50–61. 15 indexed citations
14.
Zhan, Lu, et al.. (2022). Combining Pre- and Postoperative Lymphocyte–C-Reactive Protein Ratios Can Better Predict Hepatocellular Carcinoma Prognosis After Partial Hepatectomy. Journal of Inflammation Research. Volume 15. 2229–2241. 9 indexed citations
15.
Zhao, Maoyuan, Guangwei Sun, Lu Zhan, et al.. (2022). Natural compounds targeting glycolysis as promising therapeutics for gastric cancer: A review. Frontiers in Pharmacology. 13. 1004383–1004383. 25 indexed citations
16.
Gao, Han, Xudong Peng, Lu Zhan, et al.. (2021). The role of Glabridin in antifungal and anti-inflammation effects in Aspergillus fumigatus keratitis. Experimental Eye Research. 214. 108883–108883. 12 indexed citations
17.
Yu, Huan, Jing Lin, Yingxue Zhang, Lu Zhan, & Guiqiu Zhao. (2020). Anti-inflammatory effects of astaxanthin against fungal keratitis. International Journal of Ophthalmology. 13(11). 1681–1688. 6 indexed citations
18.
Zhan, Lu, Xudong Peng, Jing Lin, et al.. (2020). Honokiol Reduces Fungal Load, Toll-Like Receptor-2, and Inflammatory Cytokines in Aspergillus fumigatus Keratitis. Investigative Ophthalmology & Visual Science. 61(4). 48–48. 38 indexed citations
19.
Yan, Junwei, et al.. (2019). Integrative transcriptomic and proteomic analysis reveals CD9/ITGA4/PI3K‐Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma. Journal of Cellular and Molecular Medicine. 24(1). 814–829. 23 indexed citations
20.
Kim, Jae‐Beom, Edward Cochran, Stephen Lee, et al.. (2010). Non-Invasive Detection of a Small Number of Bioluminescent Cancer Cells In Vivo. PLoS ONE. 5(2). e9364–e9364. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026